World's Best Scientists 2026 revealed!
Ivan Spasojevic

Ivan Spasojevic

D-Index & Metrics

Chemistry

D-Index
66
Citations
13630
World Ranking
7396
National Ranking
2183

Ivan Spasojevic publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Ivan Spasojevic sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 271 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Ivan Spasojevic D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Ivan Spasojevic sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 66 D-Index — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Ivan Spasojevic is affiliated with Duke University in the United States and has contributed extensively to medical and biochemical research. Their work spans several disciplines, with a primary focus on medicine and biochemistry, genetics, and molecular biology. Across these fields, they have produced numerous publications reflecting their engagement with complex biomedical challenges.

The scientist's research interests are varied but show particular concentration in molecular biology, oncology, pulmonary and respiratory medicine, genetics, and pediatrics, perinatology, and child health. Their main topics of work include glioma diagnosis and treatment, nanoparticle-based drug delivery, neuroinflammation and neurodegeneration mechanisms, birth, development, and health, monoclonal and polyclonal antibodies research, vitamin C and antioxidants research, and the safe handling of antineoplastic drugs.

Frequent collaboration has been a hallmark of their research approach. Key coauthors associated with their work include Ines Batinić-Haberle, Artak Tovmasyan, Huaxin Sheng, Fan Ping, and Angeles Alvarez Secord. These collaborations have contributed to a broad and diverse research output.

The publication venues where Ivan Spasojevic's research appears most often reflect their interdisciplinary expertise. These venues include:

  • Free Radical Biology and Medicine
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Oxidative Medicine and Cellular Longevity
  • Antioxidants

Among their recent papers are studies addressing therapeutic efficacy, molecular pathways, and nanoparticle technologies in medicine:

  • Efficacy of osimertinib against EGFRvIII+ glioblastoma, 2020, Oncotarget
  • H2O2-Driven Anticancer Activity of Mn Porphyrins and the Underlying Molecular Pathways, 2021, Oxidative Medicine and Cellular Longevity
  • Increasing O-GlcNAcylation is neuroprotective in young and aged brains after ischemic stroke, 2021, Experimental Neurology
  • Genetically Encoded Stealth Nanoparticles of a Zwitterionic Polypeptide-Paclitaxel Conjugate Have a Wider Therapeutic Window than Abraxane in Multiple Tumor Models, 2020, Nano Letters
  • Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd), 2025, Nature Communications

The scope of Ivan Spasojevic's research integrates molecular and clinical perspectives, emphasizing translational approaches in oncology, neurology, and pharmacology. Their profile reveals a multidisciplinary engagement with emerging biomedical technologies and therapeutic strategies.

Best Publications

  • Superoxide Dismutase Mimics: Chemistry, Pharmacology, and Therapeutic Potential

    Ines Batinić-Haberle;Júlio S. Rebouças;Ivan Spasojević

  • Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome

    Zachary J. Reitman;Genglin Jin;Edward D. Karoly;Ivan Spasojevic

  • Manganese superoxide dismutase, MnSOD and its mimics

    Sumitra Miriyala;Ivan Spasojevic;Artak Tovmasyan;Daniela Salvemini

  • Relationship among Redox Potentials, Proton Dissociation Constants of Pyrrolic Nitrogens, and in Vivo and in Vitro Superoxide Dismutating Activities of Manganese(III) and Iron(III) Water-Soluble Porphyrins

    † Ines Batinić-Haberle;Ivan Spasojević;Peter Hambright;Ludmil Benov

  • The ortho effect makes manganese(III) meso-tetrakis(N-methylpyridinium-2-yl)porphyrin a powerful and potentially useful superoxide dismutase mimic.

    Ines Batinic-Haberle;Ludmil Benov;Ivan Spasojevic;Irwin Fridovich

  • Urinary biomarkers of oxidative status.

    Dora Il'yasova;Peter Scarbrough;Ivan Spasojevic

  • SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways

    Ines Batinic-Haberle;Artak Tovmasyan;Emily R. H. Roberts;Zeljko Vujaskovic

  • A small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase (SOD) mimetic properties protects lungs from radiation-induced injury.

    Zeljko Vujaskovic;Ines Batinic-Haberle;Zahid N. Rabbani;Qin fu Feng

  • A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models

    Jayanta Bhattacharyya;Joseph J. Bellucci;Isaac Weitzhandler;Jonathan R. McDaniel

  • A joint analysis of metabolomics and genetics of breast cancer.

    Xiaohu Tang;Chao-Chieh Lin;Ivan Spasojevic;Edwin S Iversen

  • Phase I Trial of Doxorubicin-Containing Low Temperature Sensitive Liposomes in Spontaneous Canine Tumors

    Marlene L. Hauck;Susan M. LaRue;William P. Petros;Jean M. Poulson

  • New class of potent catalysts of O2˙− dismutation. Mn(III)ortho-methoxyethylpyridyl- and di-ortho-methoxyethylimidazolylporphyrins

    Ines Batinić-Haberle;Ivan Spasojević;Robert D. Stevens;Peter Hambright

  • Catalytic scavenging of peroxynitrite by isomeric Mn(III) N-methylpyridylporphyrins in the presence of reductants.

    Gerardo Ferrer-Sueta;Ines Batinić-Haberle;Ivan Spasojević;Irwin Fridovich

  • A potent superoxide dismutase mimic: manganese beta-octabromo-meso-tetrakis-(N-methylpyridinium-4-yl) porphyrin.

    Ines Batinić-Haberle;Stefan I. Liochev;Ivan Spasojević;Irwin Fridovich

  • Pure MnTBAP selectively scavenges peroxynitrite over superoxide: comparison of pure and commercial MnTBAP samples to MnTE-2-PyP in two models of oxidative stress injury, an SOD-specific Escherichia coli model and carrageenan-induced pleurisy.

    Ines Batinić-Haberle;Salvatore Cuzzocrea;Júlio S. Rebouças;Gerardo Ferrer-Sueta

  • Comparative effects of thermosensitive doxorubicin-containing liposomes and hyperthermia in human and murine tumours

    Pavel S. Yarmolenko;Yulin Zhao;Chelsea Landon;Ivan Spasojevic

  • Manganese(III) meso-tetrakis(ortho-N-alkylpyridyl)porphyrins. Synthesis, characterization, and catalysis of O2˙− dismutation

    Ines Batinić-Haberle;Ivan Spasojević;Robert. D. Stevens;Peter Hambright

  • An educational overview of the chemistry, biochemistry and therapeutic aspects of Mn porphyrins--From superoxide dismutation to H2O2-driven pathways.

    Ines Batinic-Haberle;Artak Tovmasyan;Ivan Spasojevic

  • Mn porphyrin-based superoxide dismutase (SOD) mimic, MnIIITE-2-PyP5+, targets mouse heart mitochondria.

    Ivan Spasojević;Yumin Chen;Teresa J. Noel;Yiqun Yu

  • Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.

    Ines Batinic-Haberle;Zrinka Rajic;Artak Tovmasyan;Julio S. Reboucas

  • Manganese(III) biliverdin IX dimethyl ester: a powerful catalytic scavenger of superoxide employing the Mn(III)/Mn(IV) redox couple.

    Ivan Spasojević;Ines Batinić-Haberle;Robert D. Stevens;Peter Hambright

Frequent Co-Authors

Ines Batinic-Haberle
Ines Batinic-Haberle Duke University
Mark W. Dewhirst
Mark W. Dewhirst Duke University
Irwin Fridovich
Irwin Fridovich Duke University
David S. Warner
David S. Warner Duke University
Alvin L. Crumbliss
Alvin L. Crumbliss Duke University
Daret K. St. Clair
Daret K. St. Clair University of Kentucky
Ting-Ting Huang
Ting-Ting Huang Stanford University
Ralph B. D'Agostino
Ralph B. D'Agostino Wake Forest University
Daniela Salvemini
Daniela Salvemini Saint Louis University
Darell D. Bigner
Darell D. Bigner Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to various career paths, many of which can be pursued through specialized online degrees. For example, those interested in healthcare and sales might explore the role of pharmaceutical representatives. You can learn more about how much do pharmaceutical reps make and the potential earnings in this growing field.

For students aiming to advance in clinical roles, becoming a pharmacist is a popular goal. Understanding how long does it take to become a pharmacist can help you plan your education path effectively, as it involves rigorous training and certification.

Chemistry graduates interested in forensic science can also consider careers like autopsy technicians. Insights into this profession’s education requirements, salary, and job outlook are available and can guide your decision to specialize. Check out detailed information on the autopsy technician role to evaluate if it matches your interests.

Additionally, online options for forensic science degrees make it easier to gain the credentials needed for this competitive field. Explore the forensic degree online programs that provide affordable, flexible pathways for advancing your chemistry education and career.

Best Scientists Citing Ivan Spasojevic

Trending Scientists

Recently Published Articles